Tech Company Financing Transactions
Oceana Therapeutics Funding Round
Oceana Therapeutics, based in Edison, received $23.9 million from Frazier Healthcare Partners and Kelso & Company.
Transaction Overview
Company Name
Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$23,935,000
Round
Undisclosed
Investors
Frazier Healthcare Partners (Robert More)
Kelso & Company (Frank Loverro)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2035 Lincoln Highway
Edison, NJ 08817
USA
Edison, NJ 08817
USA
Phone
Website
Email Address
Overview
The company operates as a specialty pharmaceutical company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Spitznagel
Chief Financial Officer
Andrew Einhorn
Chief Operating Officer
David Tierney
Controller
Mark Janofsky?
VP - Bus. Development
Gregory Stokes
VP - Finance
Mark Janofsky
VP - General Counsel
Steven Bosacki
VP - Marketing
Matthew Rue
VP - Sales
Richard Caulfield
Browse more venture capital transactions:
Prev: 6/30/2011: Padopolis venture capital transaction
Next: 6/30/2011: ArrayPower venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs